0 Комментарии
0 Поделились
1Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Marketplace
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Preclinical Support with Advanced Coronavirus Animal Model Services for Antiviral ResearchThe Coronavirus Disease 2019 (COVID-19) pandemic has led to the rapid development of animal models to help us understand the disease's pathogenesis, test treatments and support vaccine development. Models previously established for studying severe acute respiratory syndrome coronavirus (SARS-CoV) have been rapidly adapted for SARS-CoV-2 research. However, despite both viruses utilizing ACE2 as...0 Комментарии 0 Поделились 29 Просмотры 0 предпросмотр
-
Asia-Pacific PDX Models Market Expands Through Precision Oncology ResearchAsia-Pacific Patient Derived Xenograft (PDX) Models Market Summary: According to the latest report published by Data Bridge Market Research, the Asia-Pacific Patient Derived Xenograft (PDX) Models Market CAGR Value The world-class Asia-Pacific Patient Derived Xenograft (PDX) Models Market report analyses some of the challenges that Asia-Pacific Patient Derived Xenograft (PDX) Models...0 Комментарии 0 Поделились 388 Просмотры 0 предпросмотр
-
In Vivo CRO Market to Reach USD 10.07 Billion by 2033, Driven by Growing Global Research StandardsThe global in vivo CRO market size was valued at USD 4.95 billion in 2024, and it is projected to reach USD 5.36 billion in 2025 to USD 10.07 billion by 2033, growing at a CAGR of 8.2% during the forecast period (2025–2033). The rising international standards adoption by contract researchers in emerging nations is projected to improve demand for...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
In Vivo Toxicology Market to Reach USD 6.37 Billion by 2031 | CAGR 6.1%According to a newly published market research report by 24LifeSciences, the global In Vivo Toxicology market was valued at USD 4.27 billion in 2024 and is projected to reach USD 6.37 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 20252031. In Vivo Toxicology represents an essential component of preclinical drug development, employing whole...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
In Vivo Toxicology Market to Reach USD 6.37 Billion by 2031 | CAGR 6.1%According to a newly published market research report by 24LifeSciences, the global In Vivo Toxicology market was valued at USD 4.27 billion in 2024 and is projected to reach USD 6.37 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 20252031. In Vivo Toxicology represents an essential component of preclinical drug development, employing whole...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Is In-Vivo Imaging Advancing Research in Small Animal Models?Small Animal Imaging (In-Vivo) Market Summary: According to the latest report published by Data Bridge Market Research, the Small Animal Imaging (In-Vivo) Market CAGR Value All the statistical data including facts and figures that are included in the trustworthy Small Animal Imaging (In-Vivo) Market report is represented by using several charts, graphs or tables. This...0 Комментарии 0 Поделились 619 Просмотры 0 предпросмотр
-
Tumor Mice Model Market Size to Reach USD 2.92 Billion by 2031 at 7.1% CAGR: Key Players, Growth Trends, and Forecast InsightsTumor mice model market is witnessing sustained growth as oncology research intensifies and pharmaceutical companies seek more predictive preclinical platforms. Valued at USD 1.82 billion in 2024, the market is projected to reach USD 2.92 billion by 2031, expanding at a compound annual growth rate (CAGR) of 7.1% during the forecast period from 2025 to 2032. Discover Market Highlights –...0 Комментарии 0 Поделились 735 Просмотры 0 предпросмотр
-
Tumor Mice Model Market Size to Reach USD 2.92 Billion by 2031 at 7.1% CAGR: Key Players, Growth Trends, and Forecast InsightsTumor mice model market is witnessing sustained growth as oncology research intensifies and pharmaceutical companies seek more predictive preclinical platforms. Valued at USD 1.82 billion in 2024, the market is projected to reach USD 2.92 billion by 2031, expanding at a compound annual growth rate (CAGR) of 7.1% during the forecast period from 2025 to 2032. Discover Market Highlights –...0 Комментарии 0 Поделились 764 Просмотры 0 предпросмотр
Спонсоры
Спонсоры
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek